Atrial fibrillation (AF) is a leading, modifiable risk factor for ischaemic stroke, with 20–30% of stroke patients harbouring underlying AF. Management of AF, however, differs substantially depending on clinical context. In ischaemic stroke patients with pre-known AF, direct oral anticoagulants (DOACs) are the cornerst...
K. Wasser, Deborah Bochert, J. Leyhe et al.· Neurological Research and Pr...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.